178 related articles for article (PubMed ID: 37174017)
1. Expression of Hemangioblast Proteins in von Hippel-Lindau Disease Related Tumors.
Vergauwen E; Forsyth R; Vortmeyer A; Gläsker S
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174017
[TBL] [Abstract][Full Text] [Related]
2. Developmentally Arrested Basket/Stellate Cells in Postnatal Human Brain as Potential Tumor Cells of Origin for Cerebellar Hemangioblastoma in von Hippel-Lindau Patients.
Shively SB; Edwards NA; MacDonald TJ; Johnson KR; Diaz-Rodriguez NM; Merrill MJ; Vortmeyer AO
J Neuropathol Exp Neurol; 2022 Oct; 81(11):885-899. PubMed ID: 35980299
[TBL] [Abstract][Full Text] [Related]
3. Tumor derived vasculogenesis in von Hippel-Lindau disease-associated tumors.
Zhuang Z; Frerich JM; Huntoon K; Yang C; Merrill MJ; Abdullaev Z; Pack SD; Shively SB; Stamp G; Lonser RR
Sci Rep; 2014 Feb; 4():4102. PubMed ID: 24531117
[TBL] [Abstract][Full Text] [Related]
4. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
Park DM; Zhuang Z; Chen L; Szerlip N; Maric I; Li J; Sohn T; Kim SH; Lubensky IA; Vortmeyer AO; Rodgers GP; Oldfield EH; Lonser RR
PLoS Med; 2007 Feb; 4(2):e60. PubMed ID: 17298169
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
6. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
7. VHL-deficient vasculogenesis in hemangioblastoma.
Gläsker S; Smith J; Raffeld M; Li J; Oldfield EH; Vortmeyer AO
Exp Mol Pathol; 2014 Apr; 96(2):162-7. PubMed ID: 24394472
[TBL] [Abstract][Full Text] [Related]
8. Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease.
Shively SB; Falke EA; Li J; Tran MG; Thompson ER; Maxwell PH; Roessler E; Oldfield EH; Lonser RR; Vortmeyer AO
Mod Pathol; 2011 Aug; 24(8):1023-30. PubMed ID: 21499240
[TBL] [Abstract][Full Text] [Related]
9. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
10. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern of the von Hippel-Lindau protein in human tissues.
Los M; Jansen GH; Kaelin WG; Lips CJ; Blijham GH; Voest EE
Lab Invest; 1996 Aug; 75(2):231-8. PubMed ID: 8765323
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing and immunohistochemistry findings in von Hippel-Lindau disease.
Guo X; Gao L; Hong X; Guo D; Di W; Wang X; Xu Z; Xing B
Mol Genet Genomic Med; 2019 Sep; 7(9):e880. PubMed ID: 31317677
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
Kley N; Whaley J; Seizinger BR
Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
[TBL] [Abstract][Full Text] [Related]
14. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
[TBL] [Abstract][Full Text] [Related]
15. Von Hippel-Lindau disease.
Sano T; Horiguchi H
Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
[TBL] [Abstract][Full Text] [Related]
16. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
17. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
[TBL] [Abstract][Full Text] [Related]
18. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
19. Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.
Shen HC; Adem A; Ylaya K; Wilson A; He M; Lorang D; Hewitt SM; Pechhold K; Harlan DM; Lubensky IA; Schmidt LS; Linehan WM; Libutti SK
PLoS One; 2009; 4(4):e4897. PubMed ID: 19340311
[TBL] [Abstract][Full Text] [Related]
20. Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences.
Yousef A; Rutkowski MJ; Yalcin CE; Eren OC; Caliskan I; Tihan T
J Neurooncol; 2019 Jul; 143(3):547-552. PubMed ID: 31089924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]